MSK researchers showed that high TMB may be associated with improved survival across tumor types, but the cut-offs for high and low status will vary based on histology.
Data from the GUIDED study will be central to commercial payor discussions, a Medicare LCD reconsideration request, and eventually expansion into the primary care market.
The investment bank upgraded the company's stock to an Outperform rating from Market Perform but lowered its price target to $37 per share.
Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.
Following a pilot project, Genome Biology is to adopt a transparent peer review process at the beginning of 2019.
Indiana University School of Medicine's Aaron Carroll discusses the flaws and ways to improve peer review at the New York Times.
One of the largest repositories of molecular brain cancer data in the world, the enhanced REMBRANDT is more comprehensive than an earlier NCI-hosted version.
A pair of researchers has found that retracted papers are often still cited and call for them to be harder to access, Retraction Watch reports.
The Economist writes that an increasing number of scientific journals don't do peer review.
Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.
Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.
The University of Zurich's Ruedi Aebersold and his colleagues analyzed a dozen HeLa cell lines to find differences in gene expression, protein levels, and more.
New Scientist reports that 20 percent of human and yeast proteins are uncharacterized.
In Nature this week: protein-coding variants associated with body-fat distribution, and more.